Results 131 to 140 of about 75,394 (146)

Less may be enough: a transplant-free future for low-risk relapsed Hodgkin lymphoma. [PDF]

Transl Pediatr
Forlenza CJ, Castellino SM.
europepmc   +1 more source

[Chinese expert consensus on the application of flow cytometry in the diagnosis and detection of minimal residual disease in B-cell non-Hodgkin lymphoma (2025)].

openalex   +2 more sources

Epidemiological Profile of Non-Hodgkin's Lymphomas Seen at Kinshasa University Clinics From 2012 to 2022. [PDF]

Cancer Med
Julia MN, David A, Serge P, Fabrice B, Germain KK, Didier BN, Olive K, Bienvenu LM, Jean-Marie KM.   +8 more
europepmc   +1 more source

Outcome and Challenges in the Treatment of Pediatric Hodgkin Lymphoma With Euronet-PHL-C1 Protocol: Experience From a Resource-Limited Country. [PDF]

Cancer Med
Bechara E, Eid T, El-Dhuwaib A, Tamim H, Noun D, Borghol R, Chakhachiro Z, Abboud MR, Muwakkit S.   +8 more
europepmc   +1 more source

Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia. [PDF]

Ther Adv Drug Saf
Michot JM, Balogh Z, Brown JR, Ribrag V, Hollebecque A, Bahleda R, Quivoron C, Ammari S, Scoazec JY, Benhadji KA, Massard C.   +10 more
europepmc   +1 more source

Potential Exposure to Environmental Toxic Emissions and Increased Cancer Risk in Puerto Rico. [PDF]

Cancer Epidemiol Biomarkers Prev
Cardona-Cordero NR, Ortiz AP, Rosado-Estrada L, Torres-Rodríguez PN, Torres-Cintrón CR, Michael N, Méndez-Lázaro P, Suárez E, Ortiz-Ortiz K, Soto-Salgado M.   +9 more
europepmc   +1 more source

Routine Imaging Surveillance After Frontline ABVD Improves Outcome in High-Risk Hodgkin Lymphoma. [PDF]

Cancers (Basel)
Pugliese N, Picardi M, Vincenzi A, Giordano C, Lucania A, Severino A, Salvatore C, Mascolo M, Della Cioppa P, Pane F.   +9 more
europepmc   +1 more source

Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects. [PDF]

Cancers (Basel)
Roshani S, van Leeuwen FE, Rossetti S, Hauptmann M, Visser O, Zijlstra JM, Hutchings M, Schaapveld M, Aleman BMP.   +8 more
europepmc   +1 more source

The Relationship Between IL-6 and IL-10 Expression Levels and the Prognosis in B-Cell Non-Hodgkin Lymphoma Patients Treated with R-CHOP. [PDF]

J Inflamm Res
Dong Q, Lin W, Yu S, Qin Y, Jia C, Wang N, Xiu W, Shan W, Dong M, Liu D.   +9 more
europepmc   +1 more source

Individualized disease course prediction in high-grade non Hodgkin lymphoma (HG-NHL) patients

, 2002
G. Valet, Barbara Macnamara, Joanna Mazur, Mats Strömberg, Jan Liliemark, Anna Porwit‐MacDonald   +5 more
openalex   +1 more source